Managers

Tera Ventures Fund II seeks 55 mln euros

Tera Ventures said Sept. 13 that its second fund clinched a first close of 21 million euros ($24.4 million). The target of fund II is 55 million euros ($64 million). Tera aims to invest in 25 to 30 seed-stage tech startups located in tech hubs in Estonia, (including eligible e-residents), Finland, Denmark, Latvia, Lithuania, Poland, Sweden and the Czech Republic.

New NEA Partner Jonathan Golden draws lessons from early investing, Airbnb

Venture fundraising headed toward 18-year record

Imec.xpand raises venture-capital fund of about $136 million

Imec.xpand has raised an initial venture-capital fund of about $136 million. The fund will target early-stage and growth investments.

Conscious Venture Lab targets $50 mln for inaugural fund

Conscious Venture Lab is seeking to raise $50 million for its debut fund, according to an SEC filing. Based in Baltimore, Conscious Venture Lab is a startup accelerator.

Vivo Capital raises $532 mln for fund

Vivo Capital, a healthcare investment firm, has closed its opportunity fund at $532 million. Vivo Opportunity Fund will focus on small to mid-cap public life sciences companies.

Imec.xpand raises 117 mln euros for maiden fund

Imec's early-stage and growth fund Imec.xpand has closed its debut fund at 117 million euros, beating its initial target of 100 million euros. Based in Belgium, Imec is an international R&D and innovation hub that is active in nanoelectronics and digital technologies.

Cigna forms corporate venture fund, commits $250 mln

Health service company Cigna has launched Cigna Ventures, a new corporate venture fund focused on healthcare startups. Cigna has committed $250 million to Cigna Ventures for its debut fund.

Reprieve Cardiovascular snaps up $7 mln

Reprieve Cardiovascular, a medical device company focused on patients suffering from acute decompensated heart failure, has secured $7 million in financing. The investors included Abiomed Inc. RenalGuard launched Reprieve Cardiovascular.

Ripple Ventures raises $10 mln for debut early-stage tech fund

Toronto-based early-stage venture capital firm Ripple Ventures has closed its inaugural fund, raising $10 million in committed capital. Ripple Ventures Fund I was backed by unidentified limited partners in Canada and the United States. Launched this year by Managing Partner Matt Cohen, who will run Fund I alongside General Partner Michael Garbe, Ripple also opened an incubator space called the Tank. Fund I's first investments include Toronto telemedicine platform OnCall Health and Toronto construction technology provider Tread Technologies. The fund will invest in other companies in a range of North American technology sectors.